{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:53Z","timestamp":1761630653351},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,15]]},"DOI":"10.1097\/tp.0b013e31827df7a7","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T19:25:30Z","timestamp":1369250730000},"page":"766-772","source":"Crossref","is-referenced-by-count":18,"title":["Effect of Cytomegalovirus Immunoglobulin on the Incidence of Lymphoproliferative Disease After Lung Transplantation"],"prefix":"10.1097","volume":"95","author":[{"given":"Peter","family":"Jaksch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Murak\u00f6zy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210129","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.healun.2005.06.014","article-title":". Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.","volume":"24","author":"Benden","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R2-19-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.TP.0000128611.71038.0C","article-title":". Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease.","volume":"78","author":"Wong","year":"2004","journal-title":"Transplantation"},{"key":"R3-19-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1399-3062.2004.00073.x","article-title":". Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.","volume":"6","author":"Leung","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"R4-19-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1053-2498(01)00407-7","article-title":". Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.","volume":"21","author":"Malouf","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R5-19-20210129","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1164\/ajrccm.161.4.9901013","article-title":". High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis.","volume":"161","author":"Cohen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-19-20210129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1034\/j.1600-6143.2002.21019.x","article-title":". Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk.","volume":"2","author":"Dharnidharka","year":"2002","journal-title":"Am J Transplant"},{"key":"R7-19-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bmt.1703144","article-title":". Late onset post-transplantation lymphoproliferative disease of recipient origin following cytogenetic relapse and occult autologous haematopoietic regeneration after allogeneic bone marrow transplantation for acute myeloid leukaemia.","volume":"28","author":"Au","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R8-19-20210129","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1053-2498(01)00314-X","article-title":". Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.","volume":"20","author":"Paranjothi","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R9-19-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pbc.21072","article-title":". Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.","volume":"50","author":"Yang","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R10-19-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.0303-6987.2005.00332.x","article-title":". Subcutaneous panniculitic T-cell lymphoma in a cardiac allograft recipient.","volume":"32","author":"Bregman","year":"2005","journal-title":"J Cutan Pathol"},{"key":"R11-19-20210129","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/00007890-200112150-00012","article-title":". Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation.","volume":"72","author":"Wigle","year":"2001","journal-title":"Transplantation"},{"key":"R12-19-20210129","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.TP.0000079832.00991.EE","article-title":". Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.","volume":"76","author":"Gulley","year":"2003","journal-title":"Transplantation"},{"key":"R13-19-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1399-3062.2001.003003177.x","article-title":"Epstein-Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.","volume":"3","author":"Mentzer","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"R14-19-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.tp.0000252784.60159.96","article-title":". Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.","volume":"83","author":"Bakker","year":"2007","journal-title":"Transplantation"},{"key":"R15-19-20210129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.healun.2007.05.009","article-title":". Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.","volume":"26","author":"Ahya","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R16-19-20210129","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5858\/2006-130-176-EVPLDF","article-title":". Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.","volume":"130","author":"Peterson","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R17-19-20210129","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/intimm\/dxh099","article-title":". Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.","volume":"16","author":"Davis","year":"2004","journal-title":"Int Immunol"},{"key":"R18-19-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00007890-200207270-00009","article-title":". Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients.","volume":"74","author":"Hopwood","year":"2002","journal-title":"Transplantation"},{"key":"R19-19-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-0012.2005.00342.x","article-title":". Early onset post-transplant lymphoproliferative disease is associated with allograft localization.","volume":"19","author":"Bakker","year":"2005","journal-title":"Clin Transplant"},{"key":"R20-19-20210129","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00007890-200002270-00033","article-title":". Primary posttransplant lymphoproliferative disorder of the gallbladder in a lung transplant patient presenting with acute cholecystitis.","volume":"69","author":"Heller","year":"2000","journal-title":"Transplantation"},{"key":"R21-19-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijporl.2005.07.011","article-title":". Otolaryngological manifestations of posttransplant lymphoproliferative disorder in pediatric thoracic transplant patients.","volume":"70","author":"Herrmann","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R22-19-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.transproceed.2004.12.124","article-title":". Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"R23-19-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-0012.2005.00462.x","article-title":". Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.","volume":"20","author":"Knoop","year":"2006","journal-title":"Clin Transplant"},{"key":"R24-19-20210129","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/cncr.21391","article-title":". Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.","volume":"104","author":"Blaes","year":"2005","journal-title":"Cancer"},{"key":"R25-19-20210129","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1378\/chest.126.6.2013","article-title":". Thoracic presentations of posttransplant lymphoproliferative disorders.","volume":"126","author":"Halkos","year":"2004","journal-title":"Chest"},{"key":"R26-19-20210129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1365-2141.2003.04705.x","article-title":". Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.","volume":"123","author":"Oertel","year":"2003","journal-title":"Br J Haematol"},{"key":"R27-19-20210129","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1053-2498(02)00821-5","article-title":"Endobronchial post-transplant lymphoproliferative disorder and its management with photodynamic therapy: a case report.","volume":"22","author":"Legere","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R28-19-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-200201150-00019","article-title":". Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication.","volume":"73","author":"Verschuuren","year":"2002","journal-title":"Transplantation"},{"key":"R29-19-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-642-56352-2_2","article-title":"Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.","volume":"159","author":"Nalesnik","year":"2002","journal-title":"Recent Results Cancer Res"},{"key":"R30-19-20210129","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/00007890-199910150-00027","article-title":". Extracorporeal photochemotherapy for Epstein-Barr virus-associated lymphoma after lung transplantation.","volume":"68","author":"Schoch","year":"1999","journal-title":"Transplantation"},{"key":"R31-19-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00431-002-1120-8","article-title":". Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia.","volume":"162","author":"Wolf","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R32-19-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(07)70040-2","article-title":". Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.","volume":"8","author":"Opelz","year":"2007","journal-title":"Lancet Oncol"},{"key":"R33-19-20210129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients.","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R34-19-20210129","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":". Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R35-19-20210129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.healun.2011.10.013","article-title":". Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.","volume":"31","author":"Kremer","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R36-19-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1399-0012.2010.01332.x","article-title":". Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.","volume":"25","author":"Wudhikarn","year":"2011","journal-title":"Clin Transplant"},{"key":"R37-19-20210129","first-page":"26","article-title":". Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.","volume":"5","author":"Angel","year":"2000","journal-title":"Ann Transplant"},{"key":"R38-19-20210129","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1378\/chest.116.5.1273","article-title":". A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.","volume":"116","author":"Levine","year":"1999","journal-title":"Chest"},{"key":"R39-19-20210129","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<624::AID-IJC19>3.0.CO;2-B","article-title":". Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice.","volume":"71","author":"Abedi","year":"1997","journal-title":"Int J Cancer"},{"key":"R40-19-20210129","doi-asserted-by":"crossref","first-page":"E430","DOI":"10.1111\/j.1399-0012.2011.01464.x","article-title":". Risk factors for post-transplant lymphoproliferative disease in patients with cystic fibrosis.","volume":"25","author":"Saueressig","year":"2011","journal-title":"Clin Transplant"},{"key":"R41-19-20210129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.healun.2004.04.011","article-title":"Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.","volume":"24","author":"Raj","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R42-19-20210129","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1378\/chest.124.4.1242","article-title":". Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.","volume":"124","author":"Reams","year":"2003","journal-title":"Chest"},{"key":"R43-19-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","article-title":". Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.","volume":"22","author":"Gao","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R44-19-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.3880581","article-title":". Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.","volume":"15","author":"Ramalingam","year":"2002","journal-title":"Mod Pathol"},{"key":"R45-19-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiol.2223010456","article-title":". Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.","volume":"222","author":"Lim","year":"2002","journal-title":"Radiology"},{"key":"R46-19-20210129","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1164\/ajrccm.154.6.8970360","article-title":". Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient.","volume":"154","author":"Aris","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"R47-19-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3476(97)70173-2","article-title":". Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.","volume":"131","author":"Boyle","year":"1997","journal-title":"J Pediatr"},{"key":"R48-19-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiology.213.1.r99oc2173","article-title":"Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients.","volume":"213","author":"Pickhardt","year":"1999","journal-title":"Radiology"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e31827df7a7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T18:27:26Z","timestamp":1645122446000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201303150-00019"}},"subtitle":["Single-Center Experience With 1157 Patients"],"short-title":[],"issued":{"date-parts":[[2013,3,15]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31827df7a7","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,15]]}}}